March 25, 2004

Carlyle Groups Profiteering from War:

"The Washington investment firm, run by a who's who of Republican heavyweights, including former Secretary of State James Baker and former Defense Secretary Frank Carlucci, has put money into about 300 different companies and properties.

Those investments include United Defense Industries, a maker of combat vehicles, naval guns and missile launchers; and Sippican, a maker of submarine systems and countermeasures to protect warships.

They also include a New Jersey pharmaceutical firm called MedPointe, which just so happens to be one of only three companies licensed by the U.S. Food and Drug Administration to manufacture over-the-counter potassium iodide pills.

That's significant because potassium iodide can help protect against thyroid cancer in the event of exposure to large amounts of radiation -- from a small, easily transported nuclear weapon, say, or a terrorist attack on a nuclear power plant.

And that's significant because, in June 2002, President Bush signed into law the Public Health Security and Bioterrorism Preparedness and Response Act. It requires state and local officials to 'provide adequate protection' by distributing potassium iodide to all public facilities within a few miles of a nuclear power plant.

And that, in turn, is significant because if you're one of just a handful of authorized makers of potassium iodide, you're in a position to profit handsomely if the worst-case scenario should actually come to pass. "

Pages

Blog Archive